Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: The study will enroll individuals diagnosed with sheetapitta exhibiting classical features along with signs of Dushivisha regardless of their gender occupation socioeconomic background religion. Participants should be between 19 and 60 years of age. Cases with chronic more than 6 weeksor recurrent Sheetpitta indicating possible Dushivisha association will be included. Participants must consent to take part and share necessary information for the
Exclusion criteria
Exclusion criteria: Pregnant and lactating women Acute severe systemic illness Known hypersensitivity to study drugs Concurrent use of antihistamines corticosteroids unwilling to continue
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the efficacy of Chamapakdi Agad orally 3 gm in the management of Dushivishajanya Sheetpitta Urticaria in comparison with Haridra khanda 3gm in 28 daysTimepoint: Medicine will be given for 28 days Follow up on 7th 14th 21st 28th days | — |
Secondary
| Measure | Time frame |
|---|---|
| .Timepoint: .;To see any undued effects of champakadi agadTimepoint: Medicine will be given for 28 days Follow up upon 7th 14th 21st & 28th days | — |
Countries
India
Contacts
MAM Sumatibhai Shah Ayurved Mahavidyalaya Malwadi Hadapsar Pune